OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CAR T-Cell therapy for the management of mantle cell lymphoma
Zoufang Huang, Vivek P. Chavda, Rajashri Bezbaruah, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 28
Zoufang Huang, Vivek P. Chavda, Rajashri Bezbaruah, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Lalitkumar K. Vora, Amol D. Gholap, Keshava Jetha, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1916-1916
Open Access | Times Cited: 317
Lalitkumar K. Vora, Amol D. Gholap, Keshava Jetha, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1916-1916
Open Access | Times Cited: 317
Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease
Ghulam Mustafa Channa, Dilawar Hassan, Mahira Zeeshan, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104774-104774
Open Access | Times Cited: 30
Ghulam Mustafa Channa, Dilawar Hassan, Mahira Zeeshan, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104774-104774
Open Access | Times Cited: 30
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access
CAR-T cell therapy: Where are we now, and where are we heading?
Jiayi Wang, Liang Wang
Blood Science (2023) Vol. 5, Iss. 4, pp. 237-248
Open Access | Times Cited: 17
Jiayi Wang, Liang Wang
Blood Science (2023) Vol. 5, Iss. 4, pp. 237-248
Open Access | Times Cited: 17
Lactic acid: The culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma
Xiaopei Peng, Zhenhu He, Dandan Yuan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189164-189164
Closed Access | Times Cited: 4
Xiaopei Peng, Zhenhu He, Dandan Yuan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189164-189164
Closed Access | Times Cited: 4
CAR T-cell therapy: A collaboration between authorized treatment centers and community oncologists
Michael R. Bishop, Gary E Kay
Seminars in Oncology (2024) Vol. 51, Iss. 3-4, pp. 87-94
Open Access | Times Cited: 2
Michael R. Bishop, Gary E Kay
Seminars in Oncology (2024) Vol. 51, Iss. 3-4, pp. 87-94
Open Access | Times Cited: 2
Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma
Romane Durand, Céline Bellanger, Charlotte Kervoëlen, et al.
Haematologica (2024)
Open Access | Times Cited: 2
Romane Durand, Céline Bellanger, Charlotte Kervoëlen, et al.
Haematologica (2024)
Open Access | Times Cited: 2
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor
Gilles Salles, Jenny M. H. Chen, Ina Zhang, et al.
Advances in Therapy (2024) Vol. 41, Iss. 5, pp. 1938-1952
Open Access | Times Cited: 2
Gilles Salles, Jenny M. H. Chen, Ina Zhang, et al.
Advances in Therapy (2024) Vol. 41, Iss. 5, pp. 1938-1952
Open Access | Times Cited: 2
Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells
Phatchanat Klaihmon, Xing Kang, Surapol Issaragrisil, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10508-10508
Open Access | Times Cited: 7
Phatchanat Klaihmon, Xing Kang, Surapol Issaragrisil, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10508-10508
Open Access | Times Cited: 7
From barriers to novel strategies: smarter CAR T therapy hits hard to tumors
Muhammad Babar Khawar, Fei Ge, Ali Afzal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Muhammad Babar Khawar, Fei Ge, Ali Afzal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study
Emanuele Cencini, Natale Calomino, Marta Franceschini, et al.
Hematology Reports (2024) Vol. 16, Iss. 1, pp. 50-62
Open Access | Times Cited: 1
Emanuele Cencini, Natale Calomino, Marta Franceschini, et al.
Hematology Reports (2024) Vol. 16, Iss. 1, pp. 50-62
Open Access | Times Cited: 1
Preparation of GSH-responsive nanoparticles for combined chemo-photothermal therapy codelivering 6-MP and Ce6
Yuting Zhao, Kai Yuan, Qunzhi Hu, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105405-105405
Closed Access | Times Cited: 1
Yuting Zhao, Kai Yuan, Qunzhi Hu, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105405-105405
Closed Access | Times Cited: 1
Proteogenomics and immunopeptidomics in the development of advanced vaccines
Bedanta Bhattacharjee, Rajashri Bezbaruah, Damanbhalang Rynjah, et al.
Elsevier eBooks (2024), pp. 455-475
Closed Access | Times Cited: 1
Bedanta Bhattacharjee, Rajashri Bezbaruah, Damanbhalang Rynjah, et al.
Elsevier eBooks (2024), pp. 455-475
Closed Access | Times Cited: 1
OS IMPACTOS DA BIOTECNOLOGIA NA SAÚDE HUMANA, PERSPECTIVAS E INOVAÇÕES NO DESENVOLVIMENTO DA ÁREA
Pedro Tércio Nóbrega de Faria, ARTHUR MEDEIROS FURTADO AMARAL, ANA LUISA REIS FRAIHA, et al.
(2024)
Open Access | Times Cited: 1
Pedro Tércio Nóbrega de Faria, ARTHUR MEDEIROS FURTADO AMARAL, ANA LUISA REIS FRAIHA, et al.
(2024)
Open Access | Times Cited: 1
PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma
Jin‐Hua Liang, Wei‐Ting Wang, Rong Wang, et al.
Cancer Letters (2024) Vol. 591, pp. 216877-216877
Closed Access | Times Cited: 1
Jin‐Hua Liang, Wei‐Ting Wang, Rong Wang, et al.
Cancer Letters (2024) Vol. 591, pp. 216877-216877
Closed Access | Times Cited: 1
Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape
Αndroulla N. Miliotou, Sofia K. Georgiou‐Siafis, Charikleia Ntenti, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9181-9214
Open Access | Times Cited: 3
Αndroulla N. Miliotou, Sofia K. Georgiou‐Siafis, Charikleia Ntenti, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9181-9214
Open Access | Times Cited: 3
Advances in CAR T-cell therapy for treating patients with mantle cell lymphoma: a critical appraisal
Ruhul Amin, Ronald Darwin, Sandip Chakraborty, et al.
International Journal of Surgery (2023)
Open Access | Times Cited: 2
Ruhul Amin, Ronald Darwin, Sandip Chakraborty, et al.
International Journal of Surgery (2023)
Open Access | Times Cited: 2
Clinical and Genetic Analysis of Li-Fraumeni Syndrome with Novel TP53 Mutations
Yiping Tian, Zhengxiao Ma, Conghui Wu, et al.
Research Square (Research Square) (2024)
Open Access
Yiping Tian, Zhengxiao Ma, Conghui Wu, et al.
Research Square (Research Square) (2024)
Open Access
Nanoparticle-based vaccines and future vaccine technologies
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 477-495
Closed Access
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 477-495
Closed Access
Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas
Bei Hu, Victoria Korsos, M. Lia Palomba
Frontiers in Oncology (2024) Vol. 14
Open Access
Bei Hu, Victoria Korsos, M. Lia Palomba
Frontiers in Oncology (2024) Vol. 14
Open Access
M2 Macrophage Classification of Colorectal Cancer Reveals Intrinsic Connections with Metabolism Reprogramming and Clinical Characteristics
Fengxing Huang, Youwei Wang, Yu Shao, et al.
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 383-399
Open Access
Fengxing Huang, Youwei Wang, Yu Shao, et al.
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 383-399
Open Access
Delivery Systems Developed for Treatment Combinations to Improve Adoptive Cell Therapy
Fengfei Xu, Qiankun Ni, Ningqiang Gong, et al.
Advanced Materials (2024)
Open Access
Fengfei Xu, Qiankun Ni, Ningqiang Gong, et al.
Advanced Materials (2024)
Open Access
CAR-T: from bench to bedside
Marina O. Popova, Vladislav V. Markelov
Oncohematology (2024) Vol. 19, Iss. 3, pp. 185-198
Open Access
Marina O. Popova, Vladislav V. Markelov
Oncohematology (2024) Vol. 19, Iss. 3, pp. 185-198
Open Access
Therapeutic advances in the targeting of ROR1 in hematological cancers
Adrian Bogdan Ţigu, Raluca Munteanu, Cristian Moldovan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
Adrian Bogdan Ţigu, Raluca Munteanu, Cristian Moldovan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
Low-Frequency PPM1D Gene Mutations Associated with Inferior Treatment Response to CD19 Targeted CAR-T Cell Therapy in Mantle Cell Lymphoma
Katja Seipel, Lynn Benninger, Ulrike Bacher, et al.
Therapeutics (2024) Vol. 1, Iss. 2, pp. 95-105
Open Access
Katja Seipel, Lynn Benninger, Ulrike Bacher, et al.
Therapeutics (2024) Vol. 1, Iss. 2, pp. 95-105
Open Access
